26.490
26.49 (0%)
As of Dec 20, 2024
BridgeBio Pharma, Inc. [BBIO]
Source:
Company Overview
BridgeBio Pharma, Inc. is a commercial-stage biopharmaceutical company founded to discover, create, test and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers.
| Country | United States |
| Headquarters | palo alto, california |
| Phone Number | (650) 391-9740 |
| Industry | manufacturing |
| CEO | Neil Kumar |
| Website | www.clinicaltrials.gov |